Ross Wilson

Ross Wilson is an Adjunct Professor of Molecular Therapeutics in the Department of BIO at the University of California, Berkeley. His research focuses on engineering genome editing enzymes for cell-targeted delivery, with an emphasis on CRISPR-based technologies. The Wilson lab explores methods to enhance the delivery and efficiency of genome-editing enzymes such as Cas9, aiming to improve therapeutic applications for diseases. His work includes liver-targeted delivery, T cell and hematopoietic stem cell targeting, and efforts to improve delivery to tissues like the brain and lung. Wilson's research is driven by the goal of making genetic therapies more accessible globally.

Ross Wilson is an Assistant Adjunct Professor at the University of California, Berkeley, specializing in therapeutic genome editing, macromolecular delivery, and RNA-protein biochemistry. His research explores molecular mechanisms of RNA interference, CRISPR-Cas9 delivery systems, and the biogenesis of microRNAs. Wilson's work focuses on developing efficient methods for delivering genome-editing tools to target cells, with applications in clinical settings and genetic medicine. His studies also include structural insights into RNase P proteins and the design of cell-penetrating peptides for therapeutic delivery. His research bridges fundamental biochemistry with translational applications in genome editing and RNA biology.